Previous Close | 0.1500 |
Open | 0.0500 |
Bid | 0.0000 |
Ask | 0.0500 |
Strike | 2.50 |
Expire Date | 2024-07-19 |
Day's Range | 0.0500 - 0.0500 |
Contract Range | N/A |
Volume | |
Open Interest | 382 |
Financial Highlights and Strategic Updates
CAMBRIDGE, Mass., May 08, 2024--Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today reported first quarter 2024 financial results and provided business updates.
CAMBRIDGE, Mass., May 06, 2024--Seres Therapeutics, Inc. (Nasdaq: MCRB) ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on May 1, 2024, the Compensation and Talent Committee of Seres’ board of directors granted inducement equity grants covering an aggregate of 9,367 shares of its common stock to two new employees, consisting of stock options to purchase 6,244 shares of common stock and restricted stock units ("RSUs") covering 3,123 shares of its common